Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method

Genes are organized in functional modules (or pathways), thus their action and their dysregulation in diseases may be better understood by the identification of the modules most affected by the disease (aka disease modules, or active subnetworks). We describe how an algorithm based on the Core&Peel method is used to detect disease modules in co-expression networks of genes. We first validate Core&Peel for the general task of functional module detection by comparison with 42 methods participating in the Disease Module Identification DREAM challenge. Next, we use four specific disease test cases (colorectal cancer, prostate cancer, asthma, and rheumatoid arthritis), four state-of-the-art algorithms (ModuleDiscoverer, Degas, KeyPathwayMiner, and ClustEx), and several pathway databases to validate the proposed algorithm. Core&Peel is the only method able to find significant associations of the predicted disease module with known validated relevant pathways for all four diseases. Moreover, for the two cancer datasets, Core&Peel detects further eight relevant pathways not discovered by the other methods used in the comparative analysis. Finally, we apply Core&Peel and other methods to explore the transcriptional response of human cells to SARS-CoV-2 infection, finding supporting evidence for drug repositioning efforts at a pre-clinical level.

[1]  Raymond J. Dolan,et al.  Increased decision thresholds enhance information gathering performance in juvenile Obsessive-Compulsive Disorder (OCD) , 2017, PLoS Comput. Biol..

[2]  James Bailey,et al.  Discovery and analysis of consistent active sub-networks in cancers , 2013, BMC Bioinformatics.

[3]  Yang Chen,et al.  Open Access Research Article Identification of Responsive Gene Modules by Network-based Gene Clustering and Extending: Application to Inflammation and Angiogenesis , 2022 .

[4]  K. Mahnam,et al.  Inhibition of Viral Macrodomain of COVID-19 and Human TRPM2 by losartan , 2020 .

[5]  A. Hayday,et al.  Butyrophilins: an emerging family of immune regulators. , 2012, Trends in immunology.

[6]  J. Janssens,et al.  [Leukotriene-modifiers in asthma treatment]. , 2006, Revue medicale suisse.

[7]  Li Yu,et al.  Chemical screening identifies ROCK1 as a regulator of migrasome formation , 2020, Cell Discovery.

[8]  T. Chatila Interleukin-4 receptor signaling pathways in asthma pathogenesis. , 2004, Trends in molecular medicine.

[9]  Robert J. Moots,et al.  The multifactorial role of neutrophils in rheumatoid arthritis , 2014, Nature Reviews Rheumatology.

[10]  M. Hall,et al.  Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 , 2020, ACS central science.

[11]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[12]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[13]  Srinivasan Parthasarathy,et al.  Adapting Community Detection Algorithms for Disease Module Identification in Heterogeneous Biological Networks , 2019, Front. Genet..

[14]  V. Carnevale,et al.  TRPV1: A Target for Rational Drug Design , 2016, Pharmaceuticals.

[15]  Ron Shamir,et al.  DOMINO: a novel network-based module detection algorithm with reduced rate of false calls , 2020 .

[16]  T. Lange,et al.  Telomeres in cancer: tumour suppression and genome instability , 2017, Nature Reviews Molecular Cell Biology.

[17]  Yaniv Ziv,et al.  Revealing modular organization in the yeast transcriptional network , 2002, Nature Genetics.

[18]  A. Zakeri,et al.  Toll-like receptor-mediated involvement of innate immune cells in asthma disease. , 2017, Biochimica et biophysica acta. General subjects.

[19]  Lingjuan He,et al.  Bi-directional differentiation of single bronchioalveolar stem cells during lung repair , 2020, Cell Discovery.

[20]  J. Choudhary,et al.  Identification of protein complexes that bind to histone H3 combinatorial modifications using super-SILAC and weighted correlation network analysis , 2015, Nucleic acids research.

[21]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[23]  T. Ideker,et al.  Integrative approaches for finding modular structure in biological networks , 2013, Nature Reviews Genetics.

[24]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[25]  Alexander R. Pico,et al.  WikiPathways: Pathway Editing for the People , 2008, PLoS biology.

[26]  Daniel Marbach,et al.  Fast and Rigorous Computation of Gene and Pathway Scores from SNP-Based Summary Statistics , 2016, PLoS Comput. Biol..

[27]  M. Müller,et al.  Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2 , 2020, Nature.

[28]  Rui Huang,et al.  Overexpression of TPX2 is associated with progression and prognosis of prostate cancer , 2018, Oncology letters.

[29]  Christopher E. Brightling,et al.  Targeting TNF-α: A novel therapeutic approach for asthma , 2008 .

[30]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[31]  Elena Papaleo,et al.  New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx , 2019, PLoS Comput. Biol..

[32]  Janos X. Binder,et al.  DISEASES: Text mining and data integration of disease–gene associations , 2014, bioRxiv.

[33]  T. Bestebroer,et al.  Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture , 2014, Antimicrobial Agents and Chemotherapy.

[34]  T. Pan,et al.  Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) , 2016, The Journal of Biological Chemistry.

[35]  Jian-Piao Cai,et al.  Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset , 2015, The Journal of infectious diseases.

[36]  Richard M. Karp,et al.  DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases , 2010, PloS one.

[37]  E. Kass,et al.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer. , 2018, Annual review of cancer biology.

[38]  G. Poland,et al.  Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients , 2020, Infection Control & Hospital Epidemiology.

[39]  Makoto Tsunozaki,et al.  TRPA1: A gatekeeper for inflammation. , 2013, Annual review of physiology.

[40]  Andrea Califano,et al.  Systematic, network-based characterization of therapeutic target inhibitors , 2017, PLoS Comput. Biol..

[41]  Ji Sun,et al.  Overexpression of spindle and kinetochore–associated protein 1 contributes to the progression of prostate cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[42]  R. Albrecht,et al.  SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems , 2020, bioRxiv.

[43]  Tin Chi Nguyen,et al.  A Comprehensive Survey of Tools and Software for Active Subnetwork Identification , 2019, Front. Genet..

[44]  K. Shuai,et al.  Targeting the PIAS1 SUMO ligase pathway to control inflammation. , 2008, Trends in pharmacological sciences.

[45]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[46]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[47]  Sean R. Davis,et al.  GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..

[48]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[49]  Bhumi M. Shah,et al.  In silico studies on therapeutic agents for COVID-19: Drug repurposing approach , 2020, Life Sciences.

[50]  Donna K. Slonim,et al.  Open Community Challenge Reveals Molecular Network Modules with Key Roles in Diseases , 2018 .

[51]  Michele Ceccarelli,et al.  TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages [version 1; referees: 1 approved, 1 approved with reservations] , 2016 .

[52]  Dongdong Lin,et al.  Comparison of statistical methods for subnetwork detection in the integration of gene expression and protein interaction network , 2017, BMC Bioinformatics.

[53]  R. Harrington,et al.  Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population , 2019, Open forum infectious diseases.

[54]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[55]  Wu Zhong,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[56]  Emily G McDonald,et al.  Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) , 2020, Open forum infectious diseases.

[57]  J. Stanford,et al.  The association of fatty acids with prostate cancer risk , 2001, The Prostate.

[58]  Hsuan-Cheng Huang,et al.  Small molecules targeting severe acute respiratory syndrome human coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Penn Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[60]  William A. Lee,et al.  Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.

[61]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[62]  Marinka Zitnik,et al.  Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19 , 2020, ArXiv.

[63]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[64]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[65]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[66]  D. Raoult,et al.  Teicoplanin: an alternative drug for the treatment of COVID-19? , 2020, International Journal of Antimicrobial Agents.

[67]  P. Maes,et al.  Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice , 2009, Antimicrobial Agents and Chemotherapy.

[68]  R. Lockey,et al.  Interleukin-13 Signaling and Its Role in Asthma , 2011, The World Allergy Organization journal.

[69]  T. Hirano,et al.  Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis , 1988, European journal of immunology.

[70]  S. Jockusch,et al.  Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase , 2020, bioRxiv.

[71]  W. Jefferies,et al.  The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4+ T cells , 2014, Nature Immunology.

[72]  Harapan Harapan,et al.  Coronavirus disease 2019 (COVID-19): A literature review , 2020, Journal of Infection and Public Health.

[73]  T. Ideker,et al.  Differential network biology , 2012, Molecular systems biology.

[74]  João Pedro de Magalhães,et al.  Gene co-expression analysis for functional classification and gene–disease predictions , 2017, Briefings Bioinform..

[75]  B Marshall,et al.  Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource , 2004, Nucleic Acids Res..

[76]  Gianluca Bontempi,et al.  TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages , 2016, F1000Research.

[77]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..

[78]  S. Jockusch,et al.  A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19 , 2020, Antiviral Research.

[79]  A. Graham Pockley,et al.  Molecular chaperones and protein‐folding catalysts as intercellular signaling regulators in immunity and inflammation , 2010, Journal of leukocyte biology.

[80]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[81]  Ron Shamir,et al.  Identification of functional modules using network topology and high-throughput data , 2007, BMC Systems Biology.

[82]  Wei Zhang,et al.  Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. , 2018, Cell systems.

[83]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[84]  S. Nordgren,et al.  P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer. , 2007, Autonomic & autacoid pharmacology.

[85]  I. Thompson,et al.  Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. , 2014, Journal of the National Cancer Institute.

[86]  Lisa E. Gralinski,et al.  Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.

[87]  M. S. Mukhtar,et al.  Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis , 2020, bioRxiv.

[88]  Edwin C. K. Pang,et al.  Identification and validation of FaP1D7, a putative marker associated with the biosynthesis of methyl butanoate in cultivated strawberry (Fragaria x ananassa) , 2017, Scientific Reports.

[89]  J. W. Peterson,et al.  Chloroquine inhibition of cholera toxin , 1990, FEBS letters.

[90]  K. Arga,et al.  Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer , 2017, Scientific Reports.

[91]  Guangchuang Yu,et al.  ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. , 2016, Molecular bioSystems.

[92]  Wu Zhong,et al.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro , 2020, Cell Discovery.

[93]  Rok Sosic,et al.  Prioritizing network communities , 2018, Nature Communications.

[94]  Reinhard Guthke,et al.  ModuleDiscoverer: Identification of regulatory modules in protein-protein interaction networks , 2017, Scientific Reports.

[95]  Xu Liu,et al.  In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  Ronald N. Jones,et al.  Oritavancin Activity against Staphylococcus aureus Causing Invasive Infections in U.S. and European Hospitals: a 5-Year International Surveillance Program , 2014, Antimicrobial Agents and Chemotherapy.

[97]  Chen-Hsiang Lee,et al.  Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia , 2018, Infection and drug resistance.

[98]  F. Cheng,et al.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.

[99]  M. Shi,et al.  Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.

[100]  R. Brosh DNA helicases involved in DNA repair and their roles in cancer , 2013, Nature Reviews Cancer.

[101]  T. Ideker,et al.  Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. , 2011, Blood.

[102]  Incident wavelength and polarization dependence of spectral shifts in β-Ga2O3 UV photoluminescence , 2018, Scientific Reports.

[103]  J. Bartlett,et al.  The clinical spectrum of Staphylococcus aureus pulmonary infection. , 1990, Chest.

[104]  L. Joosten,et al.  Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritis , 2011, Proceedings of the National Academy of Sciences.

[105]  S. Cooray,et al.  The involvement of survival signaling pathways in rubella-virus induced apoptosis , 2005, Virology Journal.

[106]  T. Bíró,et al.  Transient receptor potential channels as therapeutic targets , 2011, Nature Reviews Drug Discovery.

[107]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[108]  Ruth Nussinov,et al.  Network approaches and applications in biology , 2017, PLoS Comput. Biol..

[109]  Daniel Marbach,et al.  Assessment of network module identification across complex diseases , 2019, Nature Methods.

[110]  Dhruba Kumar Bhattacharyya,et al.  (Differential) Co-Expression Analysis of Gene Expression: A Survey of Best Practices , 2020, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[111]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[112]  A. Koch,et al.  Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. , 2007, Arthritis and rheumatism.

[113]  R. Broaddus,et al.  Arachidonic acid and colorectal carcinogenesis , 2003, Molecular and Cellular Biochemistry.

[114]  M. Deli,et al.  Bicarbonate: An Ancient Concept to Defeat Pathogens in Light of Recent Findings Beneficial for COVID-19 Patients? , 2020 .

[115]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[116]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[117]  J. Gutkind,et al.  Cyclooxygenase-2 and Colorectal Cancer Chemoprevention: The β-Catenin Connection , 2006 .

[118]  Yuntao Wu,et al.  Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.

[119]  Claus Storgaard Sørensen,et al.  DNA replication and cancer: From dysfunctional replication origin activities to therapeutic opportunities. , 2016, Seminars in cancer biology.

[120]  Joe Pardo,et al.  The journey of remdesivir: from Ebola to COVID-19 , 2020, Drugs in context.

[121]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[122]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[123]  A. Katrusiak,et al.  Reinvestigation of the structure of monensin A phenylurethane sodium salt based on X-ray crystallographic and spectroscopic studies, and its activity against hospital strains of methicillin-resistant S. epidermidis and S. aureus , 2011, The Journal of Antibiotics.

[124]  M. Affolter,et al.  Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility , 2018, Nature Communications.

[125]  Jan Baumbach,et al.  KeyPathwayMiner: Detecting Case-Specific Biological Pathways Using Expression Data , 2011, Internet Math..

[126]  Miriam Baglioni,et al.  Protein complex prediction for large protein protein interaction networks with the Core&Peel method , 2016, BMC Bioinformatics.